Mortality in hepatectomy: Model for End-Stage Liver Disease as a predictor of death using the National Surgical Quality Improvement Program database

Surgery (United States)

Volumn 159, Issue 3, 2016, Pages 777-792

  Ross, Samuel W ^a   Seshadri, Ramanathan ^a   Walters, Amanda L ^a   Augenstein, Vedra A ^a   Heniford, B Todd ^a   Iannitti, David A ^a   Martinie, John B ^a   Vrochides, Dionisios ^a   Swan, Ryan Z ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL ABSCESS; ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BENIGN TUMOR; BILE DUCT CARCINOMA; BLEEDING DISORDER; BODY MASS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DIABETES MELLITUS; DISSEMINATED CANCER; END STAGE RENAL DISEASE; FEMALE; FUNCTIONAL STATUS; GALLBLADDER CANCER; HEART SURGERY; HUMAN; LENGTH OF STAY; LIVER CANCER; LIVER DISEASE; LIVER HEMANGIOMA; LIVER RESECTION; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY RATE; PARTIAL HEPATECTOMY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PRIORITY JOURNAL; REOPERATION; RESPIRATORY FAILURE; SEPSIS; SEPTIC SHOCK; SMOKING; SURGICAL MORTALITY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TOTAL QUALITY MANAGEMENT; AGE; AGED; CAUSE OF DEATH; COHORT ANALYSIS; COMPLICATION; CONFIDENCE INTERVAL; END STAGE LIVER DISEASE; FACTUAL DATABASE; FOLLOW UP; HOSPITAL MORTALITY; MORTALITY; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; STANDARDS; STATISTICAL MODEL; TIME FACTOR; TRENDS; UNITED STATES;

AGE FACTORS; AGED; CAUSE OF DEATH; COHORT STUDIES; CONFIDENCE INTERVALS; DATABASES, FACTUAL; END STAGE LIVER DISEASE; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HOSPITAL MORTALITY; HUMANS; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; QUALITY IMPROVEMENT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; TIME FACTORS; UNITED STATES;

EID: 84951053949     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2015.08.021     Document Type: Article

References (45)

1. J.B. Dimick, R.M. Wainess, J.A. Cowan, G.R. Upchurch, J.A. Knol, and L.M. Colletti National trends in the use and outcomes of hepatic resection J Am Coll Surg 199 2004 31 38
2. J.T. Mullen, D. Ribero, S.K. Reddy, M. Donadon, D. Zorzi, S. Gautam, and et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy J Am Coll Surg 204 2007 854 862
3. W. Jarnagin, W.C. Chapman, S. Curley, M. D'Angelica, C. Rosen, E. Dixon, and et al. American Hepato-Pancreato-Biliary Association, Society of Surgical Oncology, Society for Surgery of the Alimentary Tract. Surgical treatment of hepatocellular carcinoma: expert consensus statement HPB (Oxford) 12 2010 302 310
4. A. Kenjo, H. Miyata, M. Gotoh, Y. Kitagawa, M. Shimada, H. Baba, and et al. Risk stratification of 7,732 hepatectomy cases in 2011 from the National Clinical Database for Japan J Am Coll Surg 218 2014 412 422
5. A.C. Wei, R. Tung-Ping Poon, S.T. Fan, and J. Wong Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma Br J Surg 90 2003 33 41
6. S.T. Fan, C.M. Lo, C.L. Liu, C.M. Lam, W.K. Yuen, C. Yeung, and et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths Ann Surg 229 1999 322 330
7. R. Bryant, A. Laurent, C. Tayar, J.T. van Nhieu, A. Luciani, and D. Cherqui Liver resection for hepatocellular carcinoma Surg Oncol Clin N Am 17 2008 607 633
8. A. Luca, B. Angermayr, G. Bertolini, F. Koenig, G. Vizzini, M. Ploner, and et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis Liver Transpl 13 2007 1174 1180
9. S.H. Teh, J. Christein, J. Donohue, F. Que, M. Kendrick, M. Farnell, and et al. Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality J Gastrointest Surg 9 2005 1207 1215
10. S.G. Delis, A. Bakoyiannis, I. Biliatis, K. Athanassiou, N. Tassopoulos, and C. Dervenis Model for end-stage liver disease (MELD) score, as a prognostic factor for post-operative morbidity and mortality in cirrhotic patients, undergoing hepatectomy for hepatocellular carcinoma HPB (Oxford) 11 2009 351 357
11. A. Cucchetti, G. Ercolani, M. Vivarelli, M. Cescon, M. Ravaioli, G. La Barba, and et al. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis Liver Transpl 12 2006 966 971
12. F.T. Shaya, I.M. Breunig, B. Seal, C.D. Mullins, V.V. Chirikov, and N. Hanna Comparative and cost effectiveness of treatment modalities for hepatocellular carcinoma in SEER-Medicare Pharmacoeconomics 32 2014 63 74
13. C. Duan, M. Liu, Z. Zhang, K. Ma, and P. Bie Radiofrequency ablation versus hepatic resection for the treatment of early-stage hepatocellular carcinoma meeting Milan criteria: a systematic review and meta-analysis World J Surg Oncol 11 2013 190
14. J.Y. Lei, L.N. Yan, and W.T. Wang Transplantation vs resection for hepatocellular carcinoma with compensated liver function after downstaging therapy World J Gastroenterol 19 2013 4400 4408
15. M. Dhir, L.M. Smith, F. Ullrich, and et al. Pre-operative nomogram to predict risk of peri-operative mortality following liver resections for malignancy J Gastrointest Surg 14 2010 1770 1781
16. M. Dhir, S.K. Reddy, L.M. Smith, and et al. External validation of a pre-operative nomogram predicting peri-operative mortality risk after liver resections for malignancy HPB 13 2011 817 822
17. P.S. Kamath, R.H. Wiesner, M. Malinchoc, W. Kremers, T.M. Therneau, C.L. Kosberg, and et al. A model to predict survival in patients with end-stage liver disease Hepatology 33 2001 464 470
18. A.S. Befeler, D.E. Palmer, M. Hoffman, W. Longo, H. Solomon, and A.M. Di Bisceglie The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome Arch Surg 140 2005 650 654
19. B.P. Costa, F.C. Sousa, M. Serôdio, and C. Carvalho Value of MELD and MELD-based indices in surgical risk evaluation of cirrhotic patients: retrospective analysis of 190 cases World J Surg 33 2009 1711 1719
20. S.H. Teh, B.C. Sheppard, J. Schwartz, and S.L. Orloff Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis Am J Surg 195 2008 697 701
21. E. Greco, S. Nanji, I.L. Bromberg, S. Shah, A.C. Wei, C.A. Moulton, and et al. Predictors of peri-operative morbidity and liver dysfunction after hepatic resection in patients with chronic liver disease HPB (Oxford) 13 2011 559 565
22. N.N. Rahbari, C. Reissfelder, M. Koch, H. Elbers, F. Striebel, M.W. Büchler, and et al. The predictive value of postoperative clinical risk scores for outcome after hepatic resection: a validation analysis in 807 patients Ann Surg Oncol 18 2011 3640 3649
23. R.A. Schroeder, C.E. Marroquin, B.P. Bute, S. Khuri, W.G. Henderson, and P.C. Kuo Predictive indices of morbidity and mortality after liver resection Ann Surg 243 2006 373 379
24. C.W. Tzeng, A.B. Cooper, J.N. Vauthey, S.A. Curley, and T.A. Aloia Predictors of morbidity and mortality after hepatectomy in elderly patients: analysis of 7621 NSQIP patients HPB 16 2014 459 468
25. C.W. Tzeng, S.A. Curley, J.N. Vauthey, and T.A. Aloia Distinct predictors of pre- versus post-discharge venous thromboembolism after hepatectomy: analysis of 7621 NSQIP patients HPB (Oxford) 15 2013 773 780
26. S.G. de la Fuente, K.M. Bennett, and J.E. Scarborough Functional status determines postoperative outcomes in elderly patients undergoing hepatic resections J Surg Oncol 107 2013 865 870
27. American College of Surgeons. NSQIP FAQS 2014. Available from: http://site.acsnsqip.org/join-now/faq/.
28. B.L. Ecker, E.K. Bartlett, R.L. Hoffman, G.C. Karakousis, R.E. Roses, J.B. Morris, and et al. Hernia repair in the presence of ascites J Surg Res 190 2014 471 477
29. M.W. Causey, D. Nelson, E.K. Johnson, J. Maykel, B. Davis, D.E. Rivadeneira, and et al. The impact of Model for End-Stage Liver Disease-Na in predicting morbidity and mortality following elective colon cancer surgery irrespective of underlying liver disease Am J Surg 207 2014 520 526
30. V.S. Wang, and S. Saab Liver transplantation in the era of model for end-stage liver disease Liver Int 24 2004 1 8
31. D. Samuel MELD-Na as a prognostic score for cirrhotic patients: Hyponatremia and ascites are back in the game J Hepatol 50 2009 836 838
32. S.W. Biggins, W.R. Kim, N.A. Terrault, S. Saab, V. Balan, T. Schiano, and et al. Evidence-based incorporation of serum sodium concentration into MELD Gastroenterology 130 2006 1652 1660
33. F. Salerno, M. Merli, M. Cazzaniga, V. Valeriano, P. Rossi, A. Lovaria, and et al. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt J Hepatol 36 2002 494 500
34. R.S. Brown, K.S. Kumar, M.W. Russo, M. Kinkhabwala, D.L. Rudow, P. Harren, and et al. Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients Liver Transpl 8 2002 278 284
35. R.H. Wiesner, S.V. McDiarmid, P.S. Kamath, E.B. Edwards, M. Malinchoc, W.K. Kremers, and et al. MELD and PELD: application of survival models to liver allocation Liver Transpl 7 2001 567 580
36. R.B. Freeman, R.H. Wiesner, A. Harper, S.V. McDiarmid, J. Lake, E. Edwards, and et al. UNOS/OPTN Liver Disease Severity Score, UNOS/OPTN Liver and Intestine, and UNOS/OPTN Pediatric Transplantation Committees. The new liver allocation system: moving toward evidence-based transplantation policy Liver Transpl 8 2002 851 858
37. R. Wiesner, E. Edwards, R. Freeman, A. Harper, R. Kim, P. Kamath, and et al. United Network for Organ Sharing Liver Disease Severity Score Committee. Model for End-stage Liver Disease (MELD) and allocation of donor livers Gastroenterology 124 2003 91 96
38. R.B. Freeman, R.H. Wiesner, E. Edwards, A. Harper, R. Merion, et al. United Network for Organ Sharing Organ Procurement and Transplantation Network Liver and Transplantation Committee Results of the first year of the new liver allocation plan Liver Transpl 10 2004 7 15
39. V. Mazzaferro, E. Regalia, R. Doci, S. Andreola, A. Pulvirenti, F. Bozzetti, and et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
40. A.E. Ruf, W.K. Kremers, L.L. Chavez, V.I. Descalzi, L.G. Podesta, and F.G. Villamil Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone Liver Transpl 11 2005 336 343
41. W.R. Kim, S.W. Biggins, W.K. Kremers, R.H. Wiesner, P.S. Kamath, J.T. Benson, and et al. Hyponatremia and mortality among patients on the liver-transplant waiting list N Engl J Med 359 2008 1018 1026
42. R.Z. Swan, D. Sindram, J.B. Martinie, and D.A. Iannitti Operative microwave ablation for hepatocellular carcinoma: complications, recurrence, and long-term outcomes J Gastrointest Surg 17 2013 719 729
43. J.F. Buell, M.T. Thomas, S. Rudich, M. Marvin, R. Nagubandi, K.V. Ravindra, and et al. Experience with more than 500 minimally invasive hepatic procedures Ann Surg 248 2008 475 486
44. A.J. Koffron, G. Auffenberg, R. Kung, and M. Abecassis Evaluation of 300 minimally invasive liver resections at a single institution: less is more Ann Surg 246 2007 385 392 discussion 392
45. J.M. Llovet, J. Fuster, and J. Bruix Prognosis of hepatocellular carcinoma Hepatogastroenterology 49 2002 7 11